Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Saba G, Moukheiber A, Pelissolo A. Transcranial cortical stimulation in the treatment of obsessive-compulsive disorders: efficacy studies. Curr Psychiatry Rep. 2015;17(5):36.
2. Gorelick DA, Zangen A, George MS. Transcranial magnetic stimulation in the treatment of substance addiction. Ann N Y Acad Sci. 2014;1327:79-93.
3. Pascual-Leone A, Wagner T. A brief summary of the history of noninvasive brain stimulation. Annu Rev Biomed Eng. 2007;9:527-565.
4. Jwa A. Early adopters of the magical thinking cap: a study on do-it-yourself (DIY) transcranial direct current stimulation (tDCS) user community. Journal of Law and the Biosciences. 2015;2(2):292-335.
5. Hariz MI, Blomstedt P, Zrinzo L. Deep brain stimulation between 1947 and 1987: the untold story. Neurosurg Focus. 2010;29(2):E1.
6. Sironi VA. Origin and evolution of deep brain stimulation. Frontiers in Integrative Neuroscience. 2011;5:42.
7. National Academies of Sciences, Engineering, and Medicine. Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary. Available at https://nap.nationalacademies.org/read/21767/chapter/1. Last accessed July 23, 2025.
8. Milev RV, Giacobbe P, Kennedy SH, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder. Section 4: neurostimulation treatments. Canadian Journal of Psychiatry. 2016;61(9):561-575.
9. Brunoni AR, Boggio PS, De Raedt R, et al. Cognitive control therapy and transcranial direct current stimulation for depression: a randomized, double-blinded, controlled trial. J Affect Disord. 2014;162:43-49.
10. Val-Laillet D, Aarts E, Weber B, et al. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. NeuroImage: Clinical. 2015;8:1-31.
11. Oberman LM, Enticott PG, Casanova MF, et al. Transcranial magnetic stimulation in autism spectrum disorder: challenges, promise, and roadmap for future research. Autism Res. 2016;9(2):184-203.
12. Wang TR, Moosa S, Dallapiazza RF, Elias WJ, Lynch WJ. Deep brain stimulation for the treatment of drug addiction. Neurosurg Focus. 2018;45(2):E11.
13. Klein MM, Treister R, Raij T, et al. Transcranial magnetic stimulation of the brain: guidelines for pain treatment research. PAIN. 2015;156:1601-1614.
14. Li H, Wang J, Li C, Xiao Z. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults. Cochrane Database Syst Rev. 2014;(9):CD009083.
15. Naro A, Milardi D, Russo M, et al. Non-invasive brain stimulation, a tool to revert maladaptive plasticity in neuropathic pain. Front Hum Neurosci. 2016;10:376.
16. Kekic M, Boysen E, Campbell IC, Schmidt U. A systematic review of the clinical efficacy of transcranial direct current stimulation (tDCS) in psychiatric disorders. J Psychiatr Res. 2016;74:70-86.
17. Baeken C, Brunelin J, Duprat R, Vanderhasselt M-A. The application of tDCS in psychiatric disorders: a brain imaging view. Socioaffective Neuroscience and Psychology. 2016;6:29588.
18. Knotkova H, Woods AJ, Bikson M, Nitsche MA. Transcranial direct current stimulation (tDCS): what pain practitioners need to know. Practical Pain Management. 2015;15(3).
19. Rossini PM, Burke D, Chen R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: basic principles and procedures for routine clinical and research application. An updated report from an IFCN Committee. Clin Neurophysiol. 2015;126:1071-1107.
20. Won HL, Lisanby SH, Laine AF, et al. Stimulation strength and focality of electroconvulsive therapy and magnetic seizure therapy in a realistic head model. Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2014:410-413.
21. Antonenko D, Faxel M, Grittner U, et al. Effects of transcranial alternating current stimulation on cognitive functions in healthy young and older adults. Neural Plasticity. 2016;4274127.
22. Moseley P, Alderson-Day B, Ellison A, et al. Non-invasive brain stimulation and auditory verbal hallucinations: new techniques and future directions. Front Neurosci. 2016;9:515.
23. Schrader LM, Cook IA, Miller PR, et al. Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav. 2011;22:475-478.
24. Trevizol AP, Cordeiro Q. Trigeminal nerve stimulation for major depressive disorder: an updated systematic review. Arch Neurosci. 2016;4(1):e39263.
25. Bystritsky A, Korb AS, Douglas PK, et al. A review of low-intensity focused ultrasound pulsation. Brain Stimulation. 2011;4:125-136.
26. Conway CR, Cristancho P, Schlaepfer TE. Neurostimulation Treatments in Psychiatry: An Overview and Recent Advances. Available at https://www.psychiatrictimes.com/view/neurostimulation-treatments-psychiatry-overview-and-recent-advances. Last accessed July 23, 2025.
27. Cruccu G, Garcia-Larrea L, Hansson P, et al. EAN guidelines on central neurostimulation therapy in chronic pain conditions. Eur J Neurol. 2016;23:1489-1499.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth edition. Text revision. Washington, DC: American Psychiatric Association; 2022.
29. Magnezi R, Aminov E, Shmuel D, et al. Comparison between neurostimulation techniques repetitive transcranial magnetic stimulation vs electroconvulsive therapy for the treatment of resistant depression: patient preference and cost-effectiveness. Patient Prefer Adherence. 2016;10:1481-1487.
30. Davidson RJ, Lewis DA, Alloy LB, et al. Neural and behavioral substrates of mood and mood regulation. Biological Psychiatry. 2002;52:478-502.
31. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin. 2003;65:193-207.
32. Baeken C, De Raedt R. Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression. Dialogues of Clinical Neuroscience. 2011;13:139-145.
33. Diefenbach GJ, Goethe JW. Does TMS Hold Promise for Generalized Anxiety Disorder? Available at https://www.psychiatrictimes.com/view/does-tms-hold-promise-generalized-anxiety-disorder. Last accessed July 23, 2025.
34. Diefenbach GJ, Assaf M, Goethe JW, et al. Improvements in emotion regulation following repetitive transcranial magnetic stimulation for generalized anxiety disorder. J Anxiety Disord. 2016;43:1-7.
35. Deppermann S, Vennewald N, Diemer J, et al. Does rTMS alter neurocognitive functioning in patients with panic disorder/agoraphobia? An fNIRS-based investigation of prefrontal activation during a cognitive task and its modulation via sham-controlled rTMS. BioMed Research International. 2014;2014:542526.
36. Dresler T, Guhn A, Tupak SV, et al. Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. Journal of Neural Transmission. 2013;120:3-29.
37. Nishimura Y, Tanii H, Haraetal N, et al. Relationship between the prefrontal function during a cognitive task and the severity of the symptoms in patients with panic disorder: a multi-channel NIRS study. Psychiatry Research. 2009;172:168-172.
38. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352:2515-2523.
39. Hoge CW, Grossman SH, Auchterlonie JL, et al. PTSD treatment for soldiers after combat deployment: low utilization of mental health care and reasons for dropout. Psychiatric Services. 2014;65:997-1004.
40. Pradhan B, D'Amico JK, Makani R, Parikh T. Nonconventional interventions for chronic post-traumatic stress disorder: ketamine, repetitive trans-cranial magnetic stimulation (rTMS), and alternative approaches. Journal of Trauma and Dissociation. 2016;17:35-54.
41. Kohl S, Schönherr DM, Luigjes J, et al. Deep brain stimulation for treatment-refractory obsessive compulsive disorder: a systematic review. BMC Psychiatry. 2014;14:214.
42. Remington G, Foussias G, Fervaha G, et al. Treating negative symptoms in schizophrenia: an update. Curr Treat Options Psych. 2016;3:133-150.
43. Dlabac-de Lange JJ, Liemburg EJ, Bais L, et al. Effect of bilateral prefrontal rTMS on left prefrontal NAA and Glx levels in schizophrenia patients with predominant negative symptoms: an exploratory study. Brain Stimul. 2017;10(1):59-64.
44. Bauer J, Pedersen A, Scherbaum N, et al. Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Neuropsychopharmacol. 2013;38:1401-1408.
45. Yang LZ, Yang Z, Zhang X. Non-invasive brain stimulation for the treatment of nicotine addiction: potential and challenges. Neurosci Bull. 2016;32(6):550–556.
46. McClelland J, Kekic M, Bozhilova N, et al. A Randomised controlled trial of neuronavigated repetitive transcranial magnetic stimulation (rTMS) in anorexia nervosa. PLoS ONE. 2016;11:e0148606.
47. Bartholdy S, McClelland J, Kekic M, et al. Clinical outcomes and neural correlates of 20 sessions of repetitive transcranial magnetic stimulation in severe and enduring anorexia nervosa (the TIARA study): study protocol for a randomised controlled feasibility trial. Trials. 2015;16:548.
48. Burgess EE, Sylvester MD, Morse KE, et al. Effects of transcranial direct current stimulation (tDCS) on binge-eating disorder. Int J Eat Disord. 2016;49(10):930-936.
49. Sierra M, Medford N, Wyatt G, David AS. Depersonalization disorder and anxiety: a special relationship. Psychiatry Res. 2012;197:123-127.
50. Simeon D, Kozin DS, Segal K, Brenna L. Is depersonalization disorder initiated by illicit drug use any different? A survey of 394 adults. J Clin Psychiatry. 2009;70:1358-1364.
51. Baker D, Hunter E, Lawrence E, et al. Depersonalisation disorder: clinical features of 204 cases. Br J Psychiatry. 2003;182:428-433.
52. Jay E-M, Nestler S, Sierra M, et al. Ventrolateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of depersonalization disorder: a consecutive case series. Psychiatry Research. 2016;240:118-122.
53. Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry. 2015;49(12).
54. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. Journal of Electroconvulsive Therapy. 2001;17:244-253.
55. Stewart PT, Loo CK, MacPherson R, et al. The effect of electrode placement and pulse width on asystole and bradycardia during the electroconvulsive therapy stimulus. International Journal of Neuropsychopharmacology. 2011;14:585-594.
56. Loo C, Sheehan P, Pigot M, et al. A report on mood and cognitive outcomes with right unilateral ultrabrief pulse width (0.3 ms) ECT and retrospective comparison with standard pulse width right unilateral ECT. Journal of Affective Disorders. 2007;103:277-281.
57. Spaans HP, Verwijk E, Comijs HC, et al. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study. Journal of Clinical Psychiatry. 2013;74:1029-1036.
58. Verwijk E, Comijs HC, Kok RM, et al. Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review. Journal of Affective Disorders. 2012;140:233-243.
59. Kellner CH, Knapp R, Husain MM, et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010;196:226-234.
60. Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013;38:2467-2474.
61. Heijnen WT, Birkenhager TK, Wierdsma AI, et al. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol. 2010;30:616-619.
62. Haq AU, Sitzmann AF, Goldman ML, et al. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015;76:1374-1384.
63. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299-1307.
64. Prudic J, Haskett RF, McCall WV, et al. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT. 2013;29:3-12.
65. Sienaert P, Peuskens J. Anticonvulsants during electroconvulsive therapy: review and recommendations. J ECT. 2007;23:120-123.
66. van Schaik AM, Comijs HC, Sonnenberg CM, et al. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatry. 2012;20:5-17.
67. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63:1337-1344.
68. McClintock SM, Brandon AR, Husain MM, et al. A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression. J ECT. 2011;27:236-243.
69. Brakemeier EL, Merkl A, Wilbertz G, et al. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial. Biol Psychiatry. 2014;76:194-202.
70. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological Psychiatry. 2010;68:568-577.
71. Sackeim HA, Prudic J, Fuller R, et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32:244-254.
72. Fraser LM, O'Carroll RE, Ebmeier KP. The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J ECT. 2008;24:10-17.
73. Fernie G, Bennett DM, Currie J, et al. Detecting objective and subjective cognitive effects of electroconvulsive therapy: intensity, duration and test utility in a large clinical sample. Psychol Med. 2014;44:2985-2994.
74. Dobek CE, Blumberger DM, Downar J, et al. Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion. Neuropsychiatr Dis Treat. 2015;11:2975-2987.
75. Palm U, Hasan A, Strube W, Padberg F. tDCS for the treatment of depression: a comprehensive review. Eur Arch Psychiatry Clin Neurosci. 2016;266(8):681-694.
76. Nitsche MA, Müller-Dahlhaus F, Paulus W, Ziemann U. The pharmacology of neuroplasticity induced by non-invasive brain stimulation: building models for the clinical use of CNS active drugs. J Physiol. 2012;590(19):4641-4662.
77. Shivakumar V, Chhabra H, Subbanna M, et al. Effect of tDCS on auditory hallucinations in schizophrenia: Influence of catechol-O-methyltransferase (COMT) Val158Met polymorphism. Asian J Psychiatr. 2015;16:75-77.
78. Shahbabaie A, Golesorkhi M, Zamanian B, et al. State dependent effect of transcranial direct current stimulation (tDCS) on methamphetamine craving. Int J Neuropsychopharmacol. 2014;17(10):1591-1598.
79. Ferrucci R, Bortolomasi M, Brunoni AR, et al. Comparative benefits of transcranial direct current stimulation (tDCS) treatment in patients with mild/moderate vs. severe depression. Clin Neuropsychiatry. 2009;6:246-251.
80. Bikson M, Grossman P, Thomas C, et al. Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimulation. 2016;9:641–661.
81. Health Quality Ontario. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. Ont Health Technol Assess Ser. 2016;16(5):1-66.
82. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012;29:587-596.
83. Berlim MT, Van den Eynde F, Daskalakis ZJ. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J Clin Psychiatry. 2013;47:1-7.
84. Bakker N, Shahab S, Giacobbe P, et al. rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation. Brain Stimul. 2015;8:208-215.
85. Kreuzer PM, Schecklmann M, Lehner A, et al. The ACDC pilot trial: targeting the anterior cingulate by double cone coil rTMS for the treatment of depression. Brain Stimul. 2015;8:240-246.
86. Downar J, Geraci J, Salomons TV, et al. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biol Psychiatry. 2014;76:176-185.
87. Cohen RB, Boggio PS, Fregni F. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety. 2009;26:682-688.
88. Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014;75:1394-1401.
89. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010;3:187-199.
90. Richieri R, Guedj E, Michel P, et al. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J Affect Disord. 2013;151:129-135.
91. Fitzgerald PB, Grace N, Hoy KE, et al. An open label trial of clustered maintenance rTMS for patients with refractory depression. Brain Stimul. 2013;6:292-297.
92. Ren J, Li H, Palaniyappan L, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2014;51:181-189.
93. Poulet E, Galvao F, Haffen E, et al. Effects of smoking status and MADRS retardation factor on response to low frequency repetitive transcranial magnetic stimulation for depression. Eur Psychiatry. 2016;38:40-44.
94. Serafini G, Pompili M, Belvederi Murri M, et al. The effects of repetitive transcranial magnetic stimulation on cognitive performance in treatment-resistant depression: a systematic review. Neuropsychobiology. 2015;71:125-139.
95. McGirr A, Van den Eynde F, Chachamovich E, et al. Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response. Neurosci Lett. 2014;563:144-148.
96. Duprat R, Desmyter S, Rudi de R, et al. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: a fast road to remission. J Affect Disord. 2016;200:6-14.
97. Desmyter S, Duprat R, Baeken C, et al. Accelerated intermittent theta burst stimulation for suicide risk in therapy-resistant depressed patients: a randomized, sham-controlled trial. Front Hum Neurosci. 2016;10:480.
98. Kayser S, Bewernick BH, Grubert C, et al. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res. 2011;45:569-576.
99. Kayser S, Bewernick BH, Matusch A, et al. Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects. Psychol Med. 2015;45:1073-1092.
100. McClintock SM, Tirmizi O, Chansard M, et al. A systematic review of the neurocognitive effects of magnetic seizure therapy. Int Rev Psychiatry. 2011;23:413-423.
101. Schestatsky P, Janovik N, Lobato MI, et al. Rapid therapeutic response to anodal tDCS of right dorsolateral prefrontal cortex in acute mania. Brain Stimulation. 2013;6:701-703.
102. Brunoni AR, Ferrucci R, Bortolomasi M, et al. Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the major depressive episode: findings from a naturalistic study. Eur Psychiatry. 2013;28:356-361.
103. Nitsche MA, Kuo MF, Karrasch R, et al. Serotonin affects transcranial direct current-induced neuroplasticity in humans. Biol Psychiatry. 2009;66:503-508
104. Brunoni AR, Moffa AH, Fregni F, et al. Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data. Br J Psychiatry. 2016;208(6):522-531.
105. Dell'Osso B, Dobrea C, Arici C, et al. Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients: a follow-up study. CNS Spectr. 2014;19:347-354.
106. Martin DM, Alonzo A, Ho KA, et al. Continuation transcranial direct current stimulation for the prevention of relapse in major depression. J Affect Disord. 2013;25:274-278.
107. Valiengo L, Bensenor IM, Goulart AC, et al. The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases. Depress Anxiety. 2013;30:646-653.
108. Rigonatti SP, Boggio PS, Myczkowski ML, et al. Transcranial direct current stimulation and fluoxetine for the treatment of depression. Eur Psychiatry. 2008;23:74-76.
109. Brunoni AR, Valiengo L, Baccaro A, et al. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry. 2013;70:383-391.
110. Oldani L, Altamura AC, Abdelghani M, Young AH. Brain stimulation treatments in bipolar disorder: a review of the current literature. World J Biol Psychiatry. 2016;17(7):482-494.
111. Hu SH, Lai JB, Xu DR, et al. Efficacy of repetitive transcranial magnetic stimulation with quetiapine in treating bipolar II depression: a randomized, double-blinded, control study. Sci Rep. 2016;6:30537.
112. Trevizol AP, Shiozawa P, Sato IA, et al. Transcranial magnetic stimulation for anxiety symptoms: an updated systematic review and meta-analysis. Abnorm Behav Psychol. 2016;2:108.
113. Ironside M, O'Shea J, Cowen PJ, Harmer CJ. Frontal cortex stimulation reduces vigilance to threat: implications for the treatment of depression and anxiety. Biol Psychiatry. 2016;79(10):823-830.
114. Diefenbach GJ, Bragdon LB, Zertuche L, et al. Repetitive transcranial magnetic stimulation for generalised anxiety disorder: a pilot randomised, double-blind, sham-controlled trial. Br J Psychiatry. 2016;209:222-228.
115. White D, Tavakoli S. Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder. Ann Clin Psychiatry. 2015;27(3):192-196.
116. Kedzior KK, Gellersen HM, Roth Y, Zangen A. Acute reduction in anxiety after deep transcranial magnetic stimulation (DTMS) in unipolar major depression: a systematic review and meta-analysis. Psychiatry Res. 2015;230(3):971-974.
117. Watts BV, Landon B, Groft A, Young-Xu Y. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimulation. 2012;5(1):38-43.
118. Trevizol AP, Barros MD, Silva PO, et al. Transcranial magnetic stimulation for posttraumatic stress disorder: an updated systematic review and meta-analysis. Trends Psychiatry Psychother. 2016;38:50-55.
119. Philip NS, Ridout SJ, Albright SE, et al. 5-Hz transcranial magnetic stimulation for comorbid posttraumatic stress disorder and major depression. J Trauma Stress. 2016;29(1):93-96.
120. Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder: a pilot study. Brain Stimulation. 2013;6(3):377-383.
121. Elbeh KA, Elserogy YM, Khalifa HE, et al. Repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorders: double blind randomized clinical trial. Psychiatry Res. 2016;238:264-269.
122. Trevizol AP, Shiozawa P, Cook IA, et al. Transcranial magnetic stimulation for obsessive-compulsive disorder: an updated systematic review and meta-analysis. J ECT. 2016;32(4):262-266.
123. Jahangard L, Haghighi M, Shyayganfard M, et al. Repetitive transcranial magnetic stimulation improved symptoms of obsessive-compulsive disorder, but also cognitive performance: results from a randomized clinical trial with a cross-over design and sham condition. Neuropsychobiology. 2016;73:224-232.
124. Haghighi M, Shayganfard M, Jahangard L, et al. Repetitive transcranial magnetic stimulation (rTMS) improves symptoms and reduces clinical illness in patients suffering from OCD: results from a single-blind, randomized clinical trial with sham cross-over condition. J Psychiatr Res. 2015;68:238-244.
125. Landeros-Weisenberger A, Mantovani A, Motlagh MG, et al. Randomized sham controlled double-blind trial of repetitive transcranial magnetic stimulation for adults with severe Tourette syndrome. Brain Stimul. 2015;8:574-581.
126. Dollfus S, Lecardeur L, Morello R, et al. Placebo response in repetitive transcranial magnetic stimulation trials of treatment of auditory hallucinations in schizophrenia: a meta-analysis. Schizophr Bull. 2016;42:301-308.
127. Otani VH, Shiozawa P, Cordeiro Q, Uchida RR. A systematic review and meta-analysis of the use of repetitive transcranial magnetic stimulation for auditory hallucinations treatment in refractory schizophrenic patients. Int J Psychiatry Clin Pract. 2015;19:228-232.
128. Kimura H, Kanahara N, Takase M, et al. A randomized, sham-controlled study of high frequency rTMS for auditory hallucination in schizophrenia. Psychiatry Res. 2016;241:190-194.
129. Lefaucheur JP, André-Obadia N, Antal A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125:2150-206.
130. Brunelin J, Mondino M, Gassab L, et al. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. American Journal of Psychiatry. 2012;169:719-724.
131. Mondino M, Jardri R, Suaud-Chagny MF, et al. Effects of fronto-temporal transcranial direct current stimulation on auditory verbal hallucinations and resting-state functional connectivity of the left temporo-parietal junction in patients with schizophrenia. Schizophr Bull. 2016;42(2):318-326.
132. Quan WX, Zhu XL, Qiao H, et al. The effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia and the follow-up study. Neurosci Lett. 2015;584:197–201.
133. Wobrock T, Guse B, Cordes J, et al. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multi-center trial. Biol Psychiatry. 2015;77:979-988.
134. Hasan A, Guse B, Cordes J, et al. Cognitive effects of high-frequency rTMS in schizophrenia patients with predominant negative symptoms: results from a multicenter randomized sham-controlled trial. Schizophr Bull. 2016;42:608-618.
135. Gomes JS, Shiozawa P, Dias AM, et al. Left dorsolateral prefrontal cortex anodal TDCS effects on negative symptoms in schizophrenia. Brain Stimul. 2015;8(5):989-991.
136. Hoy KE, Bailey NW, Arnold SL, Fitzgerald PB. The effect of transcranial direct current stimulation on gamma activity and working memory in schizophrenia. Psychiatry Research. 2015;228:191-196.
137. Palm U, Keeser D, Hasan A, et al. Prefrontal transcranial direct current stimulation for treatment of schizophrenia with predominant negative symptoms: a double-blind, sham-controlled proof-of-concept study. Schizophrenia Bulletin. 2016;42(5):1253-1261.
138. de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2-3):135-157.
139. Strube W, Bunse T, Nitsche MA, et al. Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study. Neuropsychopharmacology. 2015;40(4):822-830.
140. Brunelin J, Hasan A, Haesebaert F, et al. Nicotine smoking prevents the effects of frontotemporal transcranial direct current stimulation (tDCS) in hallucinating patients with schizophrenia. Brain Stimul. 2015;8:1225-1227.
141. Arumugham SS, Thirthalli J, Andrade C. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia. Expert Rev Clin Pharmacol. 2016;9(9):1245-1252.
142. Kuo M-F, Paulus W, Nitsche MA. Therapeutic effects of non-invasive brain stimulation with direct currents (tDCS) in neuropsychiatric diseases. NeuroImage. 2014;85:948-960.
143. Trojak B, Meille V, Achab S, et al. Transcranial magnetic stimulation combined with nicotine replacement therapy for smoking cessation: a randomized controlled trial. Brain Stimul. 2015;8(6):1168-1174.
144. Amiaz R, Levy D, Vainiger D, et al. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction. 2009;104(4):653-660.
145. Dinur-Klein L, Dannon P, Hadar A, et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biol Psychiatry. 2014;76(9):742-749.
146. Falcone M, Bernardo L, Ashare RL, et al. Transcranial direct current brain stimulation increases ability to resist smoking. Brain Stimul. 2016;9:191-196.
147. Meng Z, Liu C, Yu C, Ma Y. Transcranial direct current stimulation of the frontal-parietal-temporal area attenuates smoking behavior. J Psychiatr Res. 2014;54:19-25.
148. Del Felice A, Bellamoli E, Formaggio E, et al. Neurophysiological, psychological and behavioural correlates of rTMS treatment in alcohol dependence. Drug Alcohol Depend. 2016;158:147-153.
149. Boggio PS, Sultani N, Fecteau S, et al. Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study. Drug Alcohol Depend. 2008;92(1-3):55-60.
150. Klauss J, Penido Pinheiro LC, Silva Merlo BL, et al. A randomized controlled trial of targeted prefrontal cortex modulation with tDCS in patients with alcohol dependence. Int J Neuropsychopharmacol. 2014;17(11):1793-1803.
151. da Silva MC, Conti CL, Klauss J, et al. Behavioral effects of transcranial direct current stimulation (tDCS) induced dorsolateral prefrontal cortex plasticity in alcohol dependence. J Physiol Paris. 2013;107(6):493-502.
152. Bolloni C, Panella R, Pedetti M, et al. Bilateral transcranial magnetic stimulation of the prefrontal cortex reduces cocaine intake: a pilot study. Front Psychiatry. 2016;7:133.
153. Conti CL, Nakamura-Palacios EM. Bilateral transcranial direct current stimulation over dorsolateral prefrontal cortex changes the drug-cued reactivity in the anterior cingulate cortex of crack-cocaine addicts. Brain Stimul. 2014;7(1):130-132.
154. Batista EK, Klauss J, Fregni F, et al. A randomized placebo-controlled trial of targeted prefrontal cortex modulation with bilateral tDCS in patients with crack-cocaine dependence. Int J Neuropsychopharmacol. 2015;18.
155. Enokibara M, Trevizol A, Shiozawa P, Cordeiro Q. Establishing an effective TMS protocol for craving in substance addiction: is it possible. Am J Addict. 2016;25(1):28-30.
156. Van den Eynde F, Guillaume S, Broadbent H, et al. Repetitive transcranial magnetic stimulation in anorexia nervosa: a pilot study. European Psychiatry. 2013;28(2):98-101.
157. McClelland J, Kekic M, Campbell IC, Schmidt U. Repetitive transcranial magnetic stimulation (rtms) treatment in enduring anorexia nervosa: a case series. Eur Eat Disord Rev. 2016;24:157-163.
158. Van den Eynde F, Claudino AM, Mogg A, et al. Repetitive transcranial magnetic stimulation reduces cue-induced food craving in bulimic disorders. Biol Psychiatry. 2010;67(8):793-795.
159. Barth KS, Rydin-Gray S, Kose S, et al. Food cravings and the effects of left prefrontal repetitive transcranial magnetic stimulation using an improved sham condition. Frontiers in Psychiatry. 2011;2:9.
160. Gay A, Jaussent I, Sigaud T, et al. A lack of clinical effect of high-frequency rTMS to dorsolateral prefrontal cortex on bulimic symptoms: a randomised, double-blind trial. Eur Eat Disord Rev. 2016;24(6):474-481.
161. Cook IA, Abrams M, Leuchter AF. Trigeminal nerve stimulation for comorbid posttraumatic stress disorder and major depressive disorder. Neuromodulation. 2016;19:299-305.
162. Trevizol AP, Sato IA, Cook IA, et al. Trigeminal nerve stimulation (TNS) for posttraumatic stress disorder and major depressive disorder: an open-label proof-of-concept trial. Epilepsy Behav. 2016;60:240-241.
163. Iuculano T, Cohen Kadosh R. The mental cost of cognitive enhancement. J Neurosci. 2013;33:4482-4486.
164. Trevizol AP, Cook IA, Lowenthal R. Trigeminal nerve stimulation (TNS) for panic disorder: an open label proof-of-concept trial. Brain Stimulation. 2016;9:161-162.
166. Hasan A, Wolff-Menzler C, Pfeiffer S, et al. Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study. Eur Arch Psychiatry Clin Neurosci. 2015;265(7):589-600.
167. Aaronson ST, Carpenter LL, Conway CR, et al. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul. 2013;6:631-640.
168. Martin JL, Martin-Sanchez E. Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs. Eur Psychiatry. 2012;27:147-155.
169. Berry SM, Broglio K, Bunker M, et al. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devices (Auckl). 2013;6:17-35.
170. Schlaepfer TE, Frick C, Zobel A, et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med. 2008;38:651-661.
171. Bajbouj M, Merkl A, Schlaepfer TE, et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol. 2010;30:273-281.
172. Morishita T, Fayad SM, Higuchi MA, et al. Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes. Neurotherapeutics. 2014;11:475-484.
173. Schlaepfer TE, Bewernick BH. Deep brain stimulation for major depression. Handb Clin Neurol. 2013;116:235-243.
174. Berlim MT, McGirr A, Van den Eynde F, et al. Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: a systematic review and exploratory meta-analysis. J Affect Disord. 2014;159:31-38.
175. Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69:150-158.
176. Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry. 2011;168:502-510.
177. Puigdemont D, Portella M, Perez-Egea R, et al. A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention. J Psychiatry Neurosci. 2015;40:224-231.
178. Baldermann JC, Schüller T, Huys D, et al. Deep brain stimulation for Tourette syndrome: a systematic review and meta-analysis. Brain Stimul. 2016;9:296-304.
179. Chang WS, Roh D, Kim C-H, Chang JW. Combined bilateral anterior cingulotomy and ventral capsule/ventral striatum deep brain stimulation for refractory obsessive-compulsive disorder with major depression: do combined procedures have a long-term benefit. Restorative Neurology and Neuroscience. 2013;31:723-732.
180. Voges J, Müller U, Bogerts B, et al. Deep brain stimulation surgery for alcohol addiction. World Neurosurg. 2013;80:S28.e21-31.
181. Kuhn J, Möller M, Treppmann JF, et al. Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction. Mol Psychiatry. 2014;19(2):145-146.
182. Zaghi S, Heine N, Fregni F. Brain stimulation for the treatment of pain: a review of costs, clinical effects, and mechanisms of treatment for three different central neuromodulatory approaches. J Pain Manag. 2009;2(3):339-352.
183. Simis M, Reidler JS, Macea DD, et al. Investigation of central nervous system dysfunction in chronic pelvic pain using magnetic resonance spectroscopy and non-invasive brain stimulation. Pain Pract. 2015;15:423-432.
184. Sundaram A, Stock V, Cruciani RA, Knotkova H. Safety of transcranial direct current stimulation (tDCS) in protocols involving human subjects. J Pain Manag. 2009;2(3):285-295.
185. Monte-Silva K, Kuo MF, Hessenthaler S, et al. Induction of late LTP-like plasticity in the human motor cortex by repeated non-invasive brain stimulation. Brain Stimul. 2013;6(3):424-432.
186. International Association for the Study of Pain. IASP Terminology. Available at https://www.iasp-pain.org/resources/terminology. Last accessed July 24, 2025.
187. Raja SN, Wallace M. Neurostimulation for neuropathic pain: outcomes and new paradigms. Pain: Clinical Updates. 2015;23(5).
188. Bouhassira D, Lantéri-minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136(3):380-387.
189. Russo JF, Sheth SA. Deep brain stimulation of the dorsal anterior cingulate cortex for the treatment of chronic neuropathic pain. Neurosurg Focus. 2015;38(6):E11.
190. National Spinal Cord Injury Statistical Center. Facts and Figures at a Glance. Available at https://msktc.org/sites/default/files/Facts-and-Figures-2024-Eng-508.pdf. Last accessed July 24, 2025.
191. Donnelly C, Eng JJ. Pain following spinal cord injury: the impact on community reintegration. Spinal Cord. 2005;43(5):278-282.
192. Klit HM, Finnerup NB, Jensen TS. Diagnosis, prevalence, characteristics, and treatment of central poststroke pain. Pain: Clinical Updates. 2015;23(3).
193. Hussain A, Erdek M. Interventional pain management for failed back surgery syndrome. Pain Practice. 2014;14:64-78.
194. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478-491.
195. Harper DE, Shah Y, Ichesco E, et al. Multivariate classification of pain-evoked brain activity in temporomandibular disorder. PAIN Reports. 2016;1:e572.
196. Hsu E, Cohen SP. Postamputation pain: epidemiology, mechanisms, and treatment. Journal of Pain Research. 2013;6:121-136.
197. Nelson JW. Acute herpes zoster neuritis and postherpetic neuralgia. Practical Pain Management. 2012;10:1-3.
198. Bentley WE, Sabia M, Goldberg ME, Wainer IW. Ketamine: an update for its use in complex regional pain syndrome and major depressive disorder. Clin Exp Pharmacol. 2015;5:2.
199. Connolly SB, Prager JP, Harden RN. A systematic review of ketamine for complex regional pain syndrome. Pain Med. 2015;16(5):943-969.
200. Martelletti P, Jensen RH, Antal A, et al. Neuromodulation of chronic headaches: position statement from the European Headache Federation. Journal of Headache and Pain. 2013;14:86.
201. Robbins MS, Starling AJ, Pringsheim TM, et al. Treatment of cluster headache: the American Headache Society evidence-based guidelines. Headache. 2016;56:1093-1106.
202. Centers for Disease Control and Prevention. Fibromyalgia. Available at https://www.cdc.gov/arthritis/fibromyalgia/index.html. Last accessed July 24, 2025.
203. Smith HS, Harris R, Clauw D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011;14:E217-E245.
204. Hou W-H, Wang T-Y, Kang J-H. The effects of add-on non-invasive brain stimulation in fibromyalgia: a meta-analysis and meta-regression of randomized controlled trials. Rheumatology (Oxford). 2016;55:1507-1517.
205. Picarelli H, Teixeira MJ, de Andrade DC, et al. Repetitive transcranial magnetic stimulation is efficacious as an add-on to pharmacological therapy in complex regional pain syndrome (CRPS) type I. J Pain. 2010;11:1203-1210.
206. Hodaj H, Alibeu J-P, Payen J-F, et al. Treatment of chronic facial pain including cluster headache by repetitive transcranial magnetic stimulation of the motor cortex with maintenance sessions: a naturalistic study. Brain Stimulation. 2015;8:801-807.
207. Malavera A, Silva FA, Fregni F, et al. Repetitive transcranial magnetic stimulation for phantom limb pain in land mine victims: a double-blinded, randomized, sham-controlled trial. J Pain. 2016;17:911-918.
208. Ma SM, Ni JX, Li XY, et al. High-frequency repetitive transcranial magnetic stimulation reduces pain in postherpetic neuralgia. Pain Med. 2015;16:2162-2170.
209. Castillo-Saavedra L, Gebodh N, Bikson M, et al. Clinically effective treatment of fibromyalgia pain with high-definition transcranial direct current stimulation: phase ii open-label dose optimization. J Pain. 2016;17:14-26.
210. Valle A, Roizenblatt S, Botte S, et al. Efficacy of anodal transcranial direct current stimulation (tDCS) for the treatment of fibromyalgia: results of a randomized, sham-controlled longitudinal clinical trial. J Pain Manag. 2009;2:353-361.
211. Donnell A, Nascimento TD, Lawrence M, et al. High-definition and non-invasive brain modulation of pain and motor dysfunction in chronic TMD. Brain Stimulation. 2015;8:1085-1092.
212. Bolognini N, Spandri V, Ferraro F, et al. Immediate and sustained effects of 5-day transcranial direct current stimulation of the motor cortex in phantom limb pain. J Pain. 2015;16:657-665.
213. Amiri MH, Tavousi SH, Mazlom SR, Manzari ZS. Effect of transcranial direct current stimulation on pain anxiety during burn wound care. Burns. 2016;42:872-876.
214. Brietzke AP, Rozisky JR, Dussan-Sarria JA, et al. Neuroplastic effects of transcranial direct current stimulation on painful symptoms reduction in chronic hepatitis c: a phase ii randomized, double blind, sham controlled trial. Front Neurosci. 2016;9:498.
215. Attal N, Ayache SS, Ciampi De Andrade D, et al. Repetitive transcranial magnetic stimulation and transcranial direct-current stimulation in neuropathic pain due to radiculopathy: a randomized sham-controlled comparative study. Pain. 2016;157(6):1224-1231.
216. Parmar VK, Gee L, Smith H, Pilitsis JG. Supraspinal stimulation for treatment of refractory pain. Clin Neurol Neurosurg. 2014;123:155-163.
217. André-Obadia N, Mertens P, Lelekov-Boissard T, et al. Is life better after motor cortex stimulation for pain control? Results at long-term and their prediction by preoperative rTMS. Pain Physician. 2014;17:53-62.
218. Fontaine D, Hamani C, Lozano A. Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg. 2009;110:251-256.
219. Lefaucheur JP, Ayache SS, Sorel M, et al. Analgesic effects of repetitive transcranial magnetic stimulation of the motor cortex in neuropathic pain: influence of theta burst stimulation priming. Eur J Pain. 2012;16:1403-1413.
220. Lefaucheur JP, Menard-Lefaucheur I, Goujon C, et al. Predictive value of rTMS in the identification of responders to epidural motor cortex stimulation therapy for pain. J Pain. 2011;12:1102-1111.
222. Boccard SG, Pereira EA, Aziz TZ. Deep brain stimulation for chronic pain. J Clin Neurosci. 2015;22(10):1537-1543.
223. Bittar RG, Kar-Purkayastha I, Owen SL, et al. Deep brain stimulation for pain relief: a meta-analysis. J Clin Neurosci. 2005;12:515-519.
224. Coffey RJ. Deep brain stimulation for chronic pain: results of two multicenter trials and a structured review. Pain Med. 2001;2(3):183-192.
225. Honey CM, Tronnier VM, Honey CR. Deep brain stimulation versus motor cortex stimulation for neuropathic pain: a minireview of the literature and proposal for future research. Computational and Structural Biotechnology Journal. 2016;14:234-237.
226. Rasche D, Rinaldi PC, Young RF, Tronnier VM. Deep brain stimulation for the treatment of various chronic pain syndromes. Neurosurg Focus. 2006;21:E8.
227. Kumar K, Toth C, Nath RK. Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery. 1997;40(4):736-746.
228. Boccard SG, Pereira EA, Moir L, et al. Long-term outcomes of deep brain stimulation for neuropathic pain. Neurosurgery. 2013;72(2):221-230.
229. Kim W, Chivukula S, Hauptman J, Pouratian N. Diffusion tensor imaging-based thalamic segmentation in deep brain stimulation for chronic pain conditions. Stereotact Funct Neurosurg. 2016;94(4):225-234.
230. Charvet LE, Kasschau M, Datta A, et al. Remotely-supervised transcranial direct current stimulation (tDCS) for clinical trials: guidelines for technology and protocols. Front Syst Neurosci. 2015;9:26.
231. Bikson M, Paneri B, Giordano J. The off-label use, utility and potential value of tDCS in the clinical care of particular neuropsychiatric conditions. Journal of Law and the Biosciences. 2016;3(3):642-646.
232. Wexler A. A pragmatic analysis of the regulation of consumer transcranial direct current stimulation (TDCS) devices in the United States. J Law Biosci. 2015;2:669-696.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.